Author: Andrew Steen

Andrew Steen has worked with life science start-up companies since 2000, establishing a broad network of contacts with venture capitalists and individuals involved in R&D and business development in pharmaceutical and biotechnology companies throughout the world. At MetaCyte Andy has played a lead role in creating deal flow. He currently serves on the boards of AnosiaVax, Inc., Gnarus Systems, Inc., Pradama Inc., and TrackFive Diagnostics, Inc., Inc., and was a board member of ImmunoTheragnostics Incorporated until its acquisition in December 2008. Andy has been actively engaged in creating the nascent life science industry in Metro Louisville since joining Louisville Medical Center Development Corporation in 2000. MetaCyte Business Lab emerged from Louisville Medical Center Development Corporation in 2002. Prior to joining LMCDC, Andy spent nearly six years with National City Bank of Kentucky where he held a number of positions, culminating as Senior Credit Analyst/Trainer/Credit Officer providing analyses of a wide variety of industries, including healthcare. Andy holds a B.A. from Transylvania University and an M.B.A. from the University of Louisville. He also attended the University of Kentucky College of Law.